Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Tandem Diabetes Care Inc

TD5A
Current price
26.8 EUR 0 EUR (0.00%)
Last closed 28.59 USD
ISIN US8753722037
Sector Healthcare
Industry Medical Devices
Exchange Frankfurt Exchange
Capitalization 2 009 700 864 USD
Yield for 12 month +48.59 %
1Y
3Y
5Y
10Y
15Y
TD5A
21.11.2021 - 28.11.2021

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the pump home screen; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs, and supported blood glucose meters; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California. Address: 12400 High Bluff Drive, San Diego, CA, United States, 92130

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

53.35 USD

P/E ratio

Dividend Yield

Current Year

+747 718 000 USD

Last Year

+801 217 000 USD

Current Quarter

+363 289 000 USD

Last Quarter

+221 910 000 USD

Current Year

+367 690 000 USD

Last Year

+412 986 000 USD

Current Quarter

+124 653 000 USD

Last Quarter

+112 794 000 USD

Key Figures TD5A

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -130 696 896 USD
Operating Margin TTM -10.7 %
PE Ratio
Return On Assets TTM -9.69 %
PEG Ratio
Return On Equity TTM -45.96 %
Wall Street Target Price 53.35 USD
Revenue TTM 854 350 976 USD
Book Value 3.62 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 31.4 %
Dividend Yield
Gross Profit TTM 412 986 000 USD
Earnings per share -1.94 USD
Diluted Eps TTM -1.94 USD
Most Recent Quarter III 2024
Quarterly Earnings Growth YOY -37 %
Profit Margin -14.84 %

Dividend Analytics TD5A

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History TD5A

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:10
Payout Ratio
Last Split Date 10.10.2017
Dividend Date 10.10.2017

Stock Valuation TD5A

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 1111.1111
Enterprise Value Revenue 2.3554
Price Sales TTM 2.3523
Enterprise Value EBITDA -10.7153
Price Book MRQ 8.4544

Financials TD5A

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators TD5A

For 52 weeks

15.79 USD 53.69 USD
50 Day MA 38.73 USD
Shares Short Prior Month 10 073 142
200 Day MA 37.83 USD
Short Ratio 7.17
Shares Short 9 091 488
Short Percent 21.53 %